In a French study, a low dose of dexamethasone in COVID-19 patients with ARDS was associated with more profound immune dysfunction on day 1 (lower expression of HLA-DR on monocytes and lower CD4+ cell counts) but also prevented fever and shortened the mechanical ventilation duration. Here, CD4 is linked to immune system disorder.